Overview

Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the effectiveness and safety of telbivudine (LdT) and lamivudine in Chinese adults.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Collaborator:
Novartis Pharmaceuticals
Treatments:
Lamivudine
Telbivudine